Effect of Music Intervention on Infants' Brainstem Encoding of Speech

Status Terminated

Clinical Trial Summary

Infants' frequency-following response (FFR) to a nonnative lexical tone, reflecting early sensory encoding of speech in the auditory system will be evaluated pre- and post- music intervention at 7 mo and 11 mo of age. The lab-controlled music intervention starts at 9 mo of age and consists of 12 sessions of social and multimodel musical activities with the aim to synchronize infants' movements with musical beats.

Clinical Trial Description

Families with healthy infants with no family history of hearing, speech and communication disorders will be recruited at 7 months of age to participate in the longitudinal music intervention study that will last for about 4 months. At recruitment, infants with 3 or more ear infections and infants who have already been/ have had participated in infant music classes will be excluded. Infants will complete a pre-intervention brainstem measures at 7 months of age upon enrolling in the study: the frequency-following response measure (FFR). Participants will have to complete the measurement to proceed to the intervention phase. At 9 months of age, families will start the 12 - session intervention in a controlled laboratory space. In the initial session, caregivers will be given a brief orientation to intervention, including introducing them to the musical toys they will be using during the sessions with their infants and the lab environment. They will also be trained on techniques through which they can synchronize the infant's movements to the experimenter's movements, such as clapping hand, tapping feet. The remaining sessions will be scheduled in groups of 2-3 infant/parent dyads. In each session, a music CD with 15 minutes of selected children's music will be played and a musically trained experimenter will facilitate the sessions to engage the infants and parents to move to musical beats, using different musical toys, such as infant drums and maracas. Parents will be instructed to not to repeat any of these activities outside of the lab setting for the period of the study. Upon finishing the intervention, infants will repeat the FFR measurement at 11 months of age. ;

Study Design

Related Conditions & MeSH terms

Infant Development

Clinical Trial Details

NCT number	NCT04509739
Study type	Interventional
Source	University of Washington
Contact
Status	Terminated
Phase	N/A
Start date	October 16, 2019
Completion date	March 15, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05793112` - INF108F in Infants With Food Protein Induced Proctocolitis	Phase 4
Recruiting	`NCT03828708` - Early Iron Exposure on the Gut Microbiota in Young Infants	N/A
Recruiting	`NCT06018064` - Investigating Fit and Satisfaction of the Prone Positioner	N/A
Not yet recruiting	`NCT06335524` - Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants	N/A
Not yet recruiting	`NCT05039918` - Neonatal Experience of Social Touch	N/A
Completed	`NCT01166867` - A Pilot Study Using Photo-plethysmographic (PPG) Camera
Completed	`NCT00791466` - Maternal Iodine Supplementation and Effects on Thyroid Function and Child Development	N/A
Completed	`NCT03331276` - Growth and Safety Study of an Infant Formula for Healthy Term Infants	N/A
Completed	`NCT05157633` - Oral Exploration of Objects and Food Diversification
Completed	`NCT05217186` - Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
Recruiting	`NCT05006989` - Blueberry Intake and Infant Gut Health	N/A
Completed	`NCT04901611` - Parental Touch Trial (Petal)	N/A
Completed	`NCT03082313` - Movement-based Infant Intervention	N/A
Recruiting	`NCT06053515` - Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication	N/A
Completed	`NCT05394883` - The SPROUT (Pilot) Project	N/A
Completed	`NCT03991949` - Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula	N/A
Active, not recruiting	`NCT03851120` - Brain Probiotic and LC-PUFA Intervention for Optimum Early Life	Phase 2
Completed	`NCT03662048` - Improving Infant Sleep Safety With the Electronic Health Record	N/A
Active, not recruiting	`NCT04749888` - Impact of the Korea Early Childhood Home-visiting Intervention	N/A
Recruiting	`NCT06230848` - Multisensory Early Oral Administration of Human Milk in Preterm Infants	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.